Fei Yao

7.1k total citations
38 papers, 849 citations indexed

About

Fei Yao is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Fei Yao has authored 38 papers receiving a total of 849 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Oncology and 7 papers in Cancer Research. Recurrent topics in Fei Yao's work include Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Liver Disease Diagnosis and Treatment (4 papers) and Spinal Cord Injury Research (4 papers). Fei Yao is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Liver Disease Diagnosis and Treatment (4 papers) and Spinal Cord Injury Research (4 papers). Fei Yao collaborates with scholars based in China, United States and Singapore. Fei Yao's co-authors include Songtao Qi, Lei Yu, Yanqing Ding, Zhang Xue-lin, Hui-xia Han, Si Gui, Qiang Wang, Qingming Wu, Jibing Chen and Kecheng Xu and has published in prestigious journals such as Applied and Environmental Microbiology, Brain Research and IEEE Access.

In The Last Decade

Fei Yao

36 papers receiving 837 citations

Peers

Countries citing papers authored by Fei Yao

Since Specialization

Citations

This map shows the geographic impact of Fei Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Yao more than expected).

Fields of papers citing papers by Fei Yao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fei Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Yao. The network helps show where Fei Yao may publish in the future.

Co-authorship network of co-authors of Fei Yao

This figure shows the co-authorship network connecting the top 25 collaborators of Fei Yao. A scholar is included among the top collaborators of Fei Yao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fei Yao. Fei Yao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Detection, molecular function and mechanisms of m5C in cancer 2025 ·Clinical and Translational Medicine ·Linhui Zhang, Yuelong Li, Liqing Li, Fei Yao, (unknown), Dingwei Ye, Yuanyuan Qu	5
2	Dynamic phosphorylation of Fascin-1 orchestrates microglial phagocytosis and neurological recovery after spinal cord injury 2025 ·Journal of Neuroinflammation ·Yanchang Liu, Fei Yao, Ziyu Li, Yan Jiang, (unknown), Shuisheng Yu, (unknown), (unknown), (unknown), Cheng Li, Juehua Jing	4
3	Galectin-3 inhibition reduces fibrotic scarring and promotes functional recovery after spinal cord injury in mice 2024 ·Cell & Bioscience ·(unknown), (unknown), (unknown), Chao Liang, Yuanzhe Zhao, Jingwen Wang, (unknown), Jian Jian Li, Jianwei Lv, (unknown), Fei Yao, Juehua Jing, (unknown)	1
4	Fascin-1 limits myosin activity in microglia to control mechanical characterization of the injured spinal cord 2024 ·Journal of Neuroinflammation ·Jinxin Huang, Xuyang Hu, (unknown), (unknown), (unknown), (unknown), Yuanzhe Zhao, Jingwen Wang, Fei Yao, Juehua Jing, Li Cheng	7
5	CSNK1D is associated with stemness and invasiveness in glioblastoma 2022 ·Pathology - Research and Practice ·Yixiong Liu, Wei He, Yu Amanda Guo, (unknown), Fei Yao, Jin Liu, Jia Chai, (unknown), Tianqi Xu, Ying Liu, Di Yang, (unknown), Mingyang Li	7
6	Detecting ALK Rearrangement with RT-PCR: A Reliable Approach Compared with Next-Generation Sequencing in Patients with NSCLC 2021 ·Molecular Diagnosis & Therapy ·Yukun Kuang, (unknown), Ji‐Yu Wang, Yifan Zheng, (unknown), Zimu Li, (unknown), Huixia Li, Yubiao Guo, Fei Yao, Changbin Zhu, Zunfu Ke, Kejing Tang	12
7	Low frequency pulsed electromagnetic field promotes differentiation of oligodendrocyte precursor cells through upregulation of miR-219-5p in vitro 2019 ·Life Sciences ·Fei Yao, Ziyu Li, Cheng Li, Liqian Zhang, (unknown), (unknown)	12
8	Cathepsin L activated by mutant p53 and Egr-1 promotes ionizing radiation-induced EMT in human NSCLC 2019 ·Journal of Experimental & Clinical Cancer Research ·Wenjuan Wang, Yajie Xiong, Xinyuan Ding, Long Wang, Yifan Zhao, Fei Yao, Ying Zhu, Xiao Shen, Caihong Tan, Zhong‐Qin Liang	40
9	Cathepsin L knockdown enhances curcumin-mediated inhibition of growth, migration, and invasion of glioma cells 2016 ·Brain Research ·Fei Yao, Yajie Xiong, Yifan Zhao, Wenjuan Wang, (unknown), Long Wang, Caihong Tan, Zhong‐Qin Liang	16
10	Cryoprotective therapy for hepatocellular carcinoma: Study of 51 patients with a single lesion 2014 ·Cryobiology ·Mohammed Alnaggar, Lizhi Niu, Jialiang Li, Fei Yao, Yuan Wang, Jianying Zeng, Ye Jin, Jibing Chen, (unknown), Kecheng Xu	9
11	Cryoprotective therapy for huge hepatocellular carcinoma: A study of 14 patients with a single lesion 2014 ·Cryobiology ·Mohammed Alnaggar, Lizhi Niu, (unknown), Fei Yao, Yuan Wang, Jianying Zeng, Ye Jin, Jibing Chen, (unknown), Kecheng Xu	4
12	Treatment of central type lung cancer by combined cryotherapy: Experiences of 47 patients 2013 ·Cryobiology ·Zhikai Zhang, Lizhi Niu, (unknown), Jianying Zeng, Fei Yao, Jibing Chen, Jialiang Li, Kecheng Xu	12
13	Two Case Reports of Pilot Percutaneous Cryosurgery in Familial Multiple Endocrine Neoplasia Type 1 2013 ·Pancreas ·Jialiang Li, Changming Zhang, Jibing Chen, Fei Yao, Jianying Zeng, Li‐Wen Huang, (unknown), Weiqun Liu, Feng Chen, (unknown), (unknown), Lizhi Niu, Jiansheng Zuo, Kecheng Xu, De‐Pei Liu	13
14	Percutaneous cryotherapy for metastatic bladder cancer: Experience with 23 patients 2013 ·Cryobiology ·(unknown), Fei Yao, Lizhi Niu, Jianying Zeng, Zhikai Zhang, Jibing Chen, Jialiang Li, Kecheng Xu	14
15	Therapeutic outcomes of combining cryotherapy, chemotherapy and DC-CIK immunotherapy in the treatment of metastatic non-small cell lung cancer 2013 ·Cryobiology ·(unknown), Lizhi Niu, (unknown), Xiaohua Wang, Jianying Zeng, Fei Yao, Feng Jiang, (unknown), Jibing Chen, Jialiang Li, Kecheng Xu	47
16	Percutaneous cryoablation for stage IV lung cancer: A retrospective analysis 2013 ·Cryobiology ·Lizhi Niu, Jibing Chen, Fei Yao, Liang Zhou, Changming Zhang, (unknown), (unknown), Yong Hu, (unknown), Feng Jiang, Jianying Zeng, Weiqun Liu, Jialiang Li, Lihua He, Feng Mu, Jiansheng Zuo, Kecheng Xu	32
17	Cryotherapy protocols for metastatic breast cancer after failure of radical surgery 2013 ·Cryobiology ·Lizhi Niu, Feng Mu, Changming Zhang, Yongqiang Li, Weiqun Liu, Feng Jiang, Li Li, Chunyan Liu, Jianying Zeng, Fei Yao, Jibing Chen, Jialiang Li, Jiansheng Zuo, Kecheng Xu	26
18	Comparison of dual- and triple-freeze protocols for hepatic cryoablation in a Tibet pig model 2012 ·Cryobiology ·Jialiang Li, Jibing Chen, Liang Zhou, Jianying Zeng, Fei Yao, Binghui Wu, Gang Fang, (unknown), Zhixian Chen, (unknown), (unknown), Lizhi Niu, Jiansheng Zuo, Kecheng Xu	15
19	IDH mutations predict longer survival and response to temozolomide in secondary glioblastoma 2011 ·Cancer Science ·Songtao Qi, Lei Yu, Si Gui, Yanqing Ding, Hui-xia Han, Zhang Xue-lin, (unknown), Fei Yao	227
20	Analysis on differences of heavy metal concentrations in different types of industrial soil in Shanghai 2009 ·WIT transactions on ecology and the environment ·(unknown), Jiancheng Kang, Weijiang Li, Jianping Zhang, Fei Yao	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact